The Transcription Factor REST Is Lost in Aggressive Breast Cancer

English version České info

The function of the tumor suppressor RE1 silencing transcription factor (REST) is lost in colon and small cell lung cancers and is known to induce anchorage-independent growth in human mammary epithelial cells. However, nothing is currently known about the role of this tumor suppressor in breast cancer. Here, we test the hypothesis that loss of REST function plays a role in breast cancer. To assay breast tumors for REST function, we developed a 24-gene signature composed of direct targets of the transcriptional repressor. Using the 24- gene signature, we identified a previously undefined RESTless breast tumor subtype. Using gene set enrichment analysis, we confirmed the aberrant expression of REST target genes in the REST–less tumors, including neuronal gene targets of REST that are normally not expressed outside the nervous system. Examination of REST mRNA identified a truncated splice variant of REST present in the REST–less tumor population, but not other tumors. Histological analysis of 182 outcome-associated breast tumor tissues also identified a subpopulation of tumors that lack full-length, functional REST and over-express the neuroendocrine marker and REST target gene Chromogranin A. Importantly, patients whose tumors were found to be REST–less using either the 24-gene signature or histology had significantly poorer prognosis and were more than twice as likely to undergo disease recurrence within the first 3 years after diagnosis. We show here that REST function is lost in breast cancer, at least in part via an alternative splicing mechanism. Patients with REST–less breast cancer undergo significantly more early disease recurrence than those with fully functional REST, regardless of estrogen receptor or HER2 status. Importantly, REST status may serve as a predictor of poor prognosis, helping to untangle the heterogeneity inherent in disease course and response to treatment. Additionally, the alternative splicing observed in REST–less breast cancer is an attractive therapeutic target.

Vyšlo v časopise: The Transcription Factor REST Is Lost in Aggressive Breast Cancer. PLoS Genet 6(6): e32767. doi:10.1371/journal.pgen.1000979
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1000979

Souhrn

Zdroje

1. ChongJA

Tapia-RamirezJ

KimS

Toledo-AralJJ

ZhengY

1995 REST: a mammalian silencer protein that restricts sodium channel gene expression to neurons. Cell 80 949 957

2. SchoenherrCJ

AndersonDJ

1995 The neuron-restrictive silencer factor (NRSF): a coordinate repressor of multiple neuron-specific genes. Science 267 1360 1363

3. SchoenherrCJ

PaquetteAJ

AndersonDJ

1996 Identification of potential target genes for the neuron-restrictive silencer factor. Proc Natl Acad Sci U S A 93 9881 9886

4. JohnsonDS

MortazaviA

MyersRM

WoldB

2007 Genome-wide mapping of in vivo protein-DNA interactions. Science 316 1497 1502

5. BruceAW

DonaldsonIJ

WoodIC

YerburySA

SadowskiMI

2004 Genome-wide analysis of repressor element 1 silencing transcription factor/neuron-restrictive silencing factor (REST/NRSF) target genes. Proc Natl Acad Sci U S A 101 10458 10463

6. Tapia-RamirezJ

EggenBJ

Peral-RubioMJ

Toledo-AralJJ

MandelG

1997 A single zinc finger motif in the silencing factor REST represses the neural-specific type II sodium channel promoter. Proc Natl Acad Sci U S A 94 1177 1182

7. HuangY

MyersSJ

DingledineR

1999 Transcriptional repression by REST: recruitment of Sin3A and histone deacetylase to neuronal genes. Nat Neurosci 2 867 872

8. RoopraA

SharlingL

WoodIC

BriggsT

BachfischerU

2000 Transcriptional repression by neuron-restrictive silencer factor is mediated via the Sin3-histone deacetylase complex. Mol Cell Biol 20 2147 2157

9. RoopraA

QaziR

SchoenikeB

DaleyTJ

MorrisonJF

2004 Localized domains of G9a-mediated histone methylation are required for silencing of neuronal genes. Mol Cell 14 727 738

10. DingN

ZhouH

EstevePO

ChinHG

KimS

2008 Mediator links epigenetic silencing of neuronal gene expression with x-linked mental retardation. Mol Cell 31 347 359

11. PalmK

MetsisM

TimmuskT

1999 Neuron-specific splicing of zinc finger transcription factor REST/NRSF/XBR is frequent in neuroblastomas and conserved in human, mouse and rat. Brain Res Mol Brain Res 72 30 39

12. CoulsonJM

EdgsonJL

WollPJ

QuinnJP

2000 A splice variant of the neuron-restrictive silencer factor repressor is expressed in small cell lung cancer: a potential role in derepression of neuroendocrine genes and a useful clinical marker. Cancer Res 60 1840 1844

13. Gurrola-DiazC

LacroixJ

DihlmannS

BeckerCM

von Knebel DoeberitzM

2003 Reduced expression of the neuron restrictive silencer factor permits transcription of glycine receptor alpha1 subunit in small-cell lung cancer cells. Oncogene 22 5636 5645

14. WestbrookTF

MartinES

SchlabachMR

LengY

LiangAC

2005 A Genetic Screen for Candidate Tumor Suppressors Identifies REST. Cell 121 837 848

15. BallasN

GrunseichC

LuDD

SpehJC

MandelG

2005 REST and its corepressors mediate plasticity of neuronal gene chromatin throughout neurogenesis. Cell 121 645 657

16. WestbrookTF

HuG

AngXL

MulliganP

PavlovaNN

2008 SCFbeta-TRCP controls oncogenic transformation and neural differentiation through REST degradation. Nature 452 370 374

17. ZuccatoC

TartariM

CrottiA

GoffredoD

ValenzaM

2003 Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes. Nat Genet 35 76 83

18. Garriga-CanutM

SchoenikeB

QaziR

BergendahlK

DaleyTJ

2006 2-Deoxy-D-glucose reduces epilepsy progression by NRSF-CtBP-dependent metabolic regulation of chromatin structure. Nat Neurosci 9 1382 1387

19. BelyaevND

WoodIC

BruceAW

StreetM

TrinhJB

2003 Distinct RE1 silencing transcription factor (REST)-containing complexes interact with different target genes. J Biol Chem

20. JohnsonR

TehCH

KunarsoG

WongKY

SrinivasanG

2008 REST regulates distinct transcriptional networks in embryonic and neural stem cells. PLoS Biol 6 e256 doi:10.1371/journal.pbio.0060256

21. LuX

WangZC

IglehartJD

ZhangX

RichardsonAL

2008 Predicting features of breast cancer with gene expression patterns. Breast Cancer Res Treat 108 191 201

22. FinakG

SadekovaS

PepinF

HallettM

MeterissianS

2006 Gene expression signatures of morphologically normal breast tissue identify basal-like tumors. Breast Cancer Res 8 R58

23. PalmK

BelluardoN

MetsisM

TimmuskT

1998 Neuronal expression of zinc finger transcription factor REST/NRSF/XBR gene. J Neurosci 18 1280 1296

24. ShimojoM

PaquetteAJ

AndersonDJ

HershLB

1999 Protein kinase A regulates cholinergic gene expression in PC12 cells: REST4 silences the silencing activity of neuron-restrictive silencer factor/REST. Mol Cell Biol 19 6788 6795

25. TimmuskT

PalmK

LendahlU

MetsisM

1999 Brain-derived neurotrophic factor expression in vivo is under the control of neuron-restrictive silencer element. J Biol Chem 274 1078 1084

26. LoiS

Haibe-KainsB

DesmedtC

LallemandF

TuttAM

2007 Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade. J Clin Oncol 25 1239 1246

27. GuardavaccaroD

FrescasD

DorrelloNV

PeschiaroliA

MultaniAS

2008 Control of chromosome stability by the beta-TrCP-REST-Mad2 axis. Nature 452 365 369

28. ReddyBY

GrecoSJ

PatelPS

TrzaskaKA

RameshwarP

2009 RE-1-silencing transcription factor shows tumor-suppressor functions and negatively regulates the oncogenic TAC1 in breast cancer cells. Proc Natl Acad Sci U S A 106 4408 4413

29. PerouCM

JeffreySS

van de RijnM

ReesCA

EisenMB

1999 Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc Natl Acad Sci U S A 96 9212 9217

30. SorlieT

PerouCM

TibshiraniR

AasT

GeislerS

2001 Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 98 10869 10874

31. VendrellJA

RobertsonKE

RavelP

BraySE

BajardA

2008 A candidate molecular signature associated with tamoxifen failure in primary breast cancer. Breast Cancer Res 10 R88

32. MorrisSR

CareyLA

2007 Gene expression profiling in breast cancer. Curr Opin Oncol 19 547 551

33. BabaF

SwartzK

van BurenR

EickhoffJ

ZhangY

2006 Syndecan-1 and syndecan-4 are overexpressed in an estrogen receptor-negative, highly proliferative breast carcinoma subtype. Breast Cancer Res Treat 98 91 98

34. HarveyJM

ClarkGM

OsborneCK

AllredDC

1999 Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol 17 1474 1481